Cargando…
Synergy Between Low Dose Metronomic Chemotherapy and the pH-Centered Approach Against Cancer
Low dose metronomic chemotherapy (MC) is becoming a mainstream treatment for cancer in veterinary medicine. Its mechanism of action is anti-angiogenesis by lowering vascular endothelial growth factor (VEGF) and increasing trombospondin-1 (TSP1). It has also been adopted as a compassionate treatment...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862380/ https://www.ncbi.nlm.nih.gov/pubmed/31683667 http://dx.doi.org/10.3390/ijms20215438 |